Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

TRENDING TOPICS:

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Dec 23 2016

Full Issue

Investigation: Pharma Raided DEA Ranks, Hiring Architects Of Agency's Opioid Enforcement Strategy

A Washington Post investigation looks at the practice of the industry hiring the very people who had designed ways to curb the opioid epidemic. Meanwhile, hundreds of Americans are dying unnecessarily because they can't get overdose medication and a company that produces kits to test for fentanyl simply re-branded an old product prone to errors to capitalize on law enforcement's demand.

The Washington Post: Drug Industry Hired Dozens Of Officials From The DEA As The Agency Tried To Curb Opioid Abuse

Pharmaceutical companies that manufacture or distribute highly addictive pain pills have hired dozens of officials from the top levels of the Drug Enforcement Administration during the past decade, according to a Washington Post investigation. The hires came after the DEA launched an aggressive campaign to curb a rising opioid epidemic that has resulted in thousands of overdose deaths each year. In 2005, the DEA began to crack down on companies that were distributing inordinate numbers of pills such as oxycodone to pain-management clinics and pharmacies around the country. (Higham, Bernstein, Rich and Crites, 12/22)

Stateline: In Drug Epidemic Resistance To Medication Costs Lives

The research is unassailable: Staying in recovery and avoiding relapse for at least a year is more than twice as likely with medications as without them. Medications also lower the risk of a fatal overdose. Addicts who quit drugs under an abstinence-based program are at a high risk of fatally overdosing if they relapse. Within days, the abstinent body’s tolerance for opioids plummets and even a small dose of the drugs can shut down the lungs. And yet as the country’s opioid epidemic worsens — every day, more than 70 Americans die from overdoses, and the numbers are climbing — only about a fifth of the people who would benefit from the medications are getting them, according to a new study by the Johns Hopkins Bloomberg School of Public Health. (Vestal, 12/23)

ProPublica: The Truth Behind The ‘New’ Police Tool For Confronting Fentanyl Menace

Heroin overdoses killed thousands nationwide last year — some 75 over just three days in Chicago. The central culprit in many of the fatalities was fentanyl, a lethally powerful compound often added to drugs sold on the street. As a result, health officials have called fentanyl a new public menace, and police forces across the U.S. are searching their neighborhoods for the dangerous painkiller. (Gabrielson, 12/22)

In other news on the crisis —

Minnesota Public Radio: Addiction Programs For Women Awarded More Than $12 Million In Grants

A dozen programs supporting women coping with addiction have been awarded more than $12 million in grants from the state of Minnesota. The programs that received the funds range from treatment programs to organizations that help women get resources like stable housing that make it easier to stay sober. (Collins, 12/22)

The Philadelphia Inquirer: As Opioid Epidemic Rages, Advocates Fear Cuts To Treatment Programs

After Holly Platts overdosed on heroin in July and was revived at the hospital with the reversal drug naloxone, she went to a rehabilitation program and stayed for 78 days. ... She could afford that lifesaving therapy because of Medicaid, the insurance program for the poor run jointly by the states and the federal government. And she was one of the lucky ones, as many Medicaid recipients have trouble finding therapy beds. Even as the opioid epidemic rages, that shortage could become worse next year, unless advocates can beat back a plan to limit federal matching funds for Medicaid drug rehab to 15 days a month. The limit would apply to all facilities with more than 16 beds. (Bond, 12/22)

WBUR: Joey Beats Another Overdose, But Drifts In And Out Of Heroin Use

Across the United States, 580 people, on average, will start using heroin today. Those who become addicted and survive will likely need to manage the disease for the rest of their lives. To get a sense of what it takes to beat this addiction, we're following Joey, from Everett. (Bebinger, 12/23)

New Orleans Times-Picayune: Deadly New Drugs Entering Baton Rouge, Coroner Warns 

A fatal drug overdose in Baton Rouge has prompted the East Baton Rouge Parish Coroner to warn the public about the influx of deadly synthetic opioids and other psychoactive drugs that can be legally purchased on the Internet. Dr. Beau Clark said a man who died on Sept. 28 was found to have ingested three drugs Clark had not previously seen in the parish: furanyl fentanyl, a high-potency fentanyl analog sold as a designer drug; Etizolam, which mimics the sedating effects of benzodiazepines like Xanax; and U-47700, an opioid analgesic known by the street names "pink" or "pinky." (Lipinski, 12/22)

New Hampshire Public Radio: Bill Proposes Involuntary Psychiatric Commitment For Severe Addiction

A bill in the New Hampshire legislature could make it legal to hospitalize someone against their will because of a drug addiction. The bill would amend the state law that allows authorities to involuntarily commit people suffering from a serious mental illness who pose a threat to themselves. (Rodolico, 12/22)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF